InvestSMART

Hydrix Limited (ASX:HYD)

ALERT: Price-sensitive ASX Announcement for HYD
Current share price for HYD : $0.004 -0.013 (-76.47%)+
Announcement
Release
30 Jan 2026 3:28PM
Price at Release
$0.017
Full Release
download
Summary
Hydrix Limited released its Appendix 4C quarterly cash flow report for the period ending 31 December 2025, highlighting $2.3 million in revenues, primarily from international cardiac and medtech product clients. A multi-year contract with SynCardia Systems, valued at $2.5 million, was a significant addition. The company ended the quarter with $582,000 in cash and cash equivalents. Net cash from operating activities was reported at $49,000, with financing facilities amounting to $6.959 million, largely drawn. Hydrix continues to leverage its innovation capabilities across services, ventures, and medical distribution to drive growth.
Key Points
  • Hydrix Limited's quarterly cash flow report for the quarter ended 31 December 2025.
  • Hydrix Limited reported $2.3 million in revenues for the quarter.
  • A significant contract with SynCardia Systems was announced, valued at $2.5 million.
  • Net cash from operating activities was $49,000 for the quarter.
  • The company had cash and cash equivalents totaling $582,000 at the end of the period.
  • Hydrix's financing facilities totaled $6.959 million, with $6.786 million drawn.
  • Hydrix Limited's mission is to deliver impactful technologies through innovation in services, ventures, and medical distribution.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.